Literature DB >> 7986948

Titanium with different oxides: in vitro studies of protein adsorption and contact activation.

B Wälivaara1, B O Aronsson, M Rodahl, J Lausmaa, P Tengvall.   

Abstract

Adsorption of albumin (HSA) and fibrinogen (Fib) from human blood plasma onto titanium surfaces with varying oxide properties was studied with an enzyme-linked immunosorbent assay. The intrinsic activation of blood coagulation (contact activation) was studied in vitro using a kallikrein-sensitive substrate. The sample surfaces were characterized with Fourier transform Raman spectroscopy. Auger electron spectroscopy and atomic force microscopy. Low Fib and high HSA adsorption was observed for all titanium samples except for the radio frequency plasma-treated and water-incubated samples, which adsorbed significantly lower amounts of both. Oxide thickness and carbon contamination showed no influence on protein adsorption or contact activation. Smooth samples with a surface roughness (Rrms) < 1 nm showed some correlation between surface wettability and adsorption of Fib and HSA, whereas rough surfaces (Rrms > 5 nm) did not. To varying degrees, all titanium surfaces indicated activation of the intrinsic pathway of coagulation as determined by their kallikrein formation in plasma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7986948     DOI: 10.1016/0142-9612(94)90038-8

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  17 in total

1.  Tissue reactions to polyethylene implants with different surface topography.

Authors:  A Rosengren; L M Bjursten; N Danielsen; H Persson; M Kober
Journal:  J Mater Sci Mater Med       Date:  1999-02       Impact factor: 3.896

2.  On the formation of fibrous capsule and fluid space around machined and porous blood plasma clot coated titanium.

Authors:  E Jansson; M Källtorp; A Johansson; P Tengvall; P Thomsen
Journal:  J Mater Sci Mater Med       Date:  2001 Oct-Dec       Impact factor: 3.896

3.  [Systematic qualitative histology of enossal implants with anodically oxidised surfaces].

Authors:  B Al-Nawas; K A Grötz; H Goetz; M Feil; H Duschner; W Wagner
Journal:  Mund Kiefer Gesichtschir       Date:  2006-07

4.  [Chemically modified, ultra-hydrophilic titanium implant surfaces].

Authors:  Frank Schwarz; Monika Herten; Marco Wieland; Michel Dard; Jürgen Becker
Journal:  Mund Kiefer Gesichtschir       Date:  2007-01

5.  [Serum-free cultivation of osteoprogenitor cells and osteoblasts to test biomaterials].

Authors:  N Duewelhenke; P Eysel
Journal:  Orthopade       Date:  2007-03       Impact factor: 1.087

6.  In vitro liberation of charged gold atoms: autometallographic tracing of gold ions released by macrophages grown on metallic gold surfaces.

Authors:  Agnete Larsen; Meredin Stoltenberg; Gorm Danscher
Journal:  Histochem Cell Biol       Date:  2007-06-05       Impact factor: 4.304

7.  Surface modification of titanium by hydrothermal treatment in Mg-containing solution and early osteoblast responses.

Authors:  Xingling Shi; Masaharu Nakagawa; Giichiro Kawachi; Lingli Xu; Kunio Ishikawa
Journal:  J Mater Sci Mater Med       Date:  2012-03-04       Impact factor: 3.896

8.  Mesenchymal stem cell adhesion and spreading on microwave plasma-nitrided titanium alloy.

Authors:  William C Clem; Valery V Konovalov; S Chowdhury; Yogesh K Vohra; Shane A Catledge; Susan L Bellis
Journal:  J Biomed Mater Res A       Date:  2006-02       Impact factor: 4.396

9.  Short term evaluation of material blood compatibility using a microchannel array.

Authors:  Kimi Kurotobi; Akiko Yamamoto; Akemi Kikuta; Takao Hanawa
Journal:  J Mater Sci Mater Med       Date:  2007-02-03       Impact factor: 4.727

10.  Bone apposition to titanium implants biocoated with recombinant human bone morphogenetic protein-2 (rhBMP-2). A pilot study in dogs.

Authors:  Jürgen Becker; Axel Kirsch; Frank Schwarz; Maria Chatzinikolaidou; Daniel Rothamel; Vojislav Lekovic; Markus Laub; Herbert Peter Jennissen
Journal:  Clin Oral Investig       Date:  2006-05-09       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.